STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
NYMX NYMOX PHARMACEUTICALS CORPORATION StockScouter® Report
3
StockScouter® Score
NYMOX PHARMACEUTICALS CORPORATION, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
Concerns
- Short-term relative price momentum exhibits meaningful weakness. Negative
- Shares are being sold by financial institutions. Slightly negative for a small company like NYMX
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
A
N/A
A